Submission for OMB Review; 30-Day Comment Request; Generic Clearance for Surveys of Customers and Partners of the Office of Extramural Research of the National Institutes of Health, 6909-6910 [2014-02399]

Download as PDF 6909 Federal Register / Vol. 79, No. 24 / Wednesday, February 5, 2014 / Notices March 26 and 27, 2014, oral presentations from the public will be scheduled between approximately 1 p.m. and 2 p.m. Those individuals interested in making formal oral presentations should notify the contact person and submit a brief statement of the general nature of the evidence or arguments they wish to present, the names and addresses of proposed participants, and an indication of the approximate time requested to make their presentation on or before March 10, 2014. Time allotted for each presentation may be limited. If the number of registrants requesting to speak is greater than can be reasonably accommodated during the scheduled open public hearing session, FDA may conduct a lottery to determine the speakers for the scheduled open public hearing session. The contact person will notify interested persons regarding their request to speak by March 13, 2014. Persons attending FDA’s advisory committee meetings are advised that the Agency is not responsible for providing access to electrical outlets. FDA welcomes the attendance of the public at its advisory committee meetings and will make every effort to accommodate persons with physical disabilities or special needs. If you require special accommodations due to a disability, please contact James Clark, Conference Management Staff, at james.clark@fda.hhs.gov or 301–796– 5293 at least 7 days in advance of the meeting. FDA is committed to the orderly conduct of its advisory committee meetings. Please visit our Web site at https://www.fda.gov/Advisory Committees/AboutAdvisoryCommittees/ ucm111462.htm for procedures on public conduct during advisory committee meetings. Notice of this meeting is given under the Federal Advisory Committee Act (5 U.S.C. app. 2). Dated: January 29, 2014. Jill Hartzler Warner, Acting Associate Commissioner for Special Medical Programs. [FR Doc. 2014–02395 Filed 2–4–14; 8:45 am] BILLING CODE 4160–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Submission for OMB Review; 30-Day Comment Request; Generic Clearance for Surveys of Customers and Partners of the Office of Extramural Research of the National Institutes of Health Summary: Under the provisions of Section 3507(a)(1)(D) of the Paperwork Reduction Act of 1995, the National Institutes of Health (NIH) has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection listed below. This proposed information collection was previously published in the Federal Register on November 22, 2013, pages 70062–70063 and allowed 60 days for public comment. No public comments were received. The purpose of this notice is to allow an additional 30 days for public comment. The Office of Extramural Research (OER), the National Institutes of Health (NIH), may not conduct or sponsor, and the respondent is not required to respond to, an information collection that has been extended, revised, or implemented on or after October 1, 1995, unless it displays a currently valid OMB control number. Direct Comments to OMB: Written comments and/or suggestions regarding the item(s) contained in this notice, especially regarding the estimated public burden and associated response time, should be directed to the: Office of Management and Budget, Office of Regulatory Affairs, OIRA_submission@ omb.eop.gov or by fax to 202–395–6974, Attention: NIH Desk Officer. Comment Due Date: Comments regarding this information collection are best assured of having their full effect if received within 30 days of the date of this publication. For Further Information: To obtain a copy of the data collection plans and instruments or request more information on the proposed project contact: Dr. Paula Y. Goodwin, Special Assistant to the Director, Office of Extramural Programs, OER, NIH, 6705 Rockledge Drive, Suite 350, Bethesda, MD 20892, or call non-toll-free number (301) 496– 9232 or Email your request, including your address to: OEPMailbox@ mail.nih.gov. Formal requests for additional plans and instruments must be requested in writing. Proposed Collection: Generic Clearance for Surveys of Customers and Partners of the Office of Extramural Research of the National Institutes of Health—0925–0627—Extension—Office of the Director (OD), Office of Extramural Research (OER), Office of Extramural Programs (OEP), National Institutes of Health (NIH). Need and Use of Information Collection: OER develops, coordinates the implementation of, and evaluates NIH-wide policies and procedures for the award of extramural funds. To move forward with our initiatives to ensure success in accomplishing the NIH mission, input from partners and customers is essential. Quality management principles have been integrated into OER’s culture and these surveys will provide customer satisfaction input on various elements of OER’s business processes. The approximately 14 (10 quantitative and 4 qualitative) customer satisfaction surveys that will be conducted under this generic clearance will gather and measure customer and partner satisfaction with OER processes and operations. The data collected from these surveys will provide the feedback to track and gauge satisfaction with NIH’s statutorily mandated operations and processes. OER/OD/NIH will present data and outcomes from these surveys to inform the NIH staff, officers, leadership, advisory committees, and other decision-making bodies as appropriate. Based on feedback from these stakeholders, OER/OD/NIH will formulate improvement plans and take action when necessary. OMB approval is requested for 3 years. There are no costs to respondents other than their time. The total estimated annualized burden hours are 2,485. Estimated Annualized Burden Hours mstockstill on DSK4VPTVN1PROD with NOTICES QUANTITATIVE SURVEY Type of respondent Number of respondents Science professionals, applicants, reviewers, Institutional Officials ................ Adult Science Trainees .................................................................................... General Public ................................................................................................. Science professionals, applicants, reviewers, Institutional Officials ................ Adult Science Trainees .................................................................................... VerDate Mar<15>2010 16:50 Feb 04, 2014 Jkt 232001 PO 00000 Frm 00029 Fmt 4703 Sfmt 4703 Number of responses per respondent 3,820 2,000 4,000 12 6 E:\FR\FM\05FEN1.SGM 1 1 1 1 1 05FEN1 Average burden per response (in hours) 15/60 15/60 15/60 1 1 Total annual burden hours 995 500 1,000 12 6 6910 Federal Register / Vol. 79, No. 24 / Wednesday, February 5, 2014 / Notices QUANTITATIVE SURVEY—Continued Type of respondent Number of respondents General Public ................................................................................................. 12 Dated: January 30, 2014. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2014–02399 Filed 2–4–14; 8:45 am] [FR Doc. 2014–02313 Filed 2–4–14; 8:45 am] BILLING CODE 4140–01–P BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting National Institute on Minority Health and Health Disparities; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. mstockstill on DSK4VPTVN1PROD with NOTICES Dated: January 29, 2014. Seleda Perryman, Chief Project Clearance Officer, OPERA, National Institutes of Health. Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable materials, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; Time-Sensitive Obesity Review. Date: February 24, 2014. Time: 11:00 a.m. to 1:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Michele L. Barnard, Ph.D., Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 753, 6707 Democracy Boulevard, Bethesda, MD 20892–2542, (301) 594–8898, barnardm@extra.niddk.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS). Name of Committee: National Institute on Minority Health and Health Disparities Special Emphasis Panel; NIMHD Basic and Applied Biomedical Research on Minority Health and Health Disparities (R01). Date: March 12–13, 2014. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Doubletree by Hilton Silver Spring, 8727 Coleville Road, Silver Spring, MD 20910. Contact Person: Maryline Laude-Sharp, Ph.D., Scientific Review Officer, National Institute on Minority Health, and Health Disparities, National Institutes of Health, 6707 Democracy Blvd., Suite 800, Bethesda, MD 20892, (301) 451–9536, mlaudesharp@ mail.nih.gov. VerDate Mar<15>2010 16:50 Feb 04, 2014 Jkt 232001 Dated: January 30, 2014. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2014–02312 Filed 2–4–14; 8:45 am] BILLING CODE 4140–01–P PO 00000 Frm 00030 Fmt 4703 Sfmt 4703 Number of responses per respondent 1 Average burden per response (in hours) Total annual burden hours 1 12 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of meetings of the Board of Scientific Counselors for Basic Sciences, National Cancer Institute and the Board of Scientific Counselors for Clinical Sciences and Epidemiology, National Cancer Institute. The meetings will be closed to the public as indicated below in accordance with the provisions set forth in section 552b(c)(6), Title 5 U.S.C., as amended for the review, discussion, and evaluation of individual intramural programs and projects conducted by the National Cancer Institute, including consideration of personnel qualifications and performance, and the competence of individual investigators, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Board of Scientific Counselors for Basic Sciences, National Cancer Institute. Date: March 10, 2014. Time: 9:00 a.m. to 12:50 p.m. Agenda: To review and evaluate personal qualifications and performance, and competence of individual investigators. Place: National Institutes of Health, Building 31, 31 Center Drive, C-Wing, 6th Floor, Conference Room 6, Bethesda, MD 20892. Contact Person: Mehrdad M. Tondravi, Ph.D., Executive Secretary, Institute Review Office, Office of the Director, National Cancer Institute, National Institutes of Health, 9609 Medical Center Drive, Room 2W464, Rockville, MD 20850, 240–276–5664, tondravim@mail.nih.gov. Name of Committee: Board of Scientific Counselors for Clinical Sciences and Epidemiology, National Cancer Institute. Date: March 11, 2014. Time: 8:30 a.m. to 3:40 p.m. Agenda: To review and evaluate personal qualifications and performance, and competence of individual investigators. Place: National Institutes of Health, Building 31, 31 Center Drive, C Wing, 6th Floor, Conference Room 6, Bethesda, MD 20892. E:\FR\FM\05FEN1.SGM 05FEN1

Agencies

[Federal Register Volume 79, Number 24 (Wednesday, February 5, 2014)]
[Notices]
[Pages 6909-6910]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-02399]

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

Submission for OMB Review; 30-Day Comment Request; Generic
Clearance for Surveys of Customers and Partners of the Office of
Extramural Research of the National Institutes of Health

Summary: Under the provisions of Section 3507(a)(1)(D) of the
Paperwork Reduction Act of 1995, the National Institutes of Health
(NIH) has submitted to the Office of Management and Budget (OMB) a
request for review and approval of the information collection listed
below. This proposed information collection was previously published in
the Federal Register on November 22, 2013, pages 70062-70063 and
allowed 60 days for public comment. No public comments were received.
The purpose of this notice is to allow an additional 30 days for public
comment. The Office of Extramural Research (OER), the National
Institutes of Health (NIH), may not conduct or sponsor, and the
respondent is not required to respond to, an information collection
that has been extended, revised, or implemented on or after October 1,
1995, unless it displays a currently valid OMB control number.
Direct Comments to OMB: Written comments and/or suggestions
regarding the item(s) contained in this notice, especially regarding
the estimated public burden and associated response time, should be
directed to the: Office of Management and Budget, Office of Regulatory
Affairs, OIRA_submission@omb.eop.gov or by fax to 202-395-6974,
Attention: NIH Desk Officer.
Comment Due Date: Comments regarding this information collection
are best assured of having their full effect if received within 30 days
of the date of this publication.
For Further Information: To obtain a copy of the data collection
plans and instruments or request more information on the proposed
project contact: Dr. Paula Y. Goodwin, Special Assistant to the
Director, Office of Extramural Programs, OER, NIH, 6705 Rockledge
Drive, Suite 350, Bethesda, MD 20892, or call non-toll-free number
(301) 496-9232 or Email your request, including your address to:
OEPMailbox@mail.nih.gov. Formal requests for additional plans and
instruments must be requested in writing.
Proposed Collection: Generic Clearance for Surveys of Customers and
Partners of the Office of Extramural Research of the National
Institutes of Health--0925-0627--Extension--Office of the Director
(OD), Office of Extramural Research (OER), Office of Extramural
Programs (OEP), National Institutes of Health (NIH).
Need and Use of Information Collection: OER develops, coordinates
the implementation of, and evaluates NIH-wide policies and procedures
for the award of extramural funds. To move forward with our initiatives
to ensure success in accomplishing the NIH mission, input from partners
and customers is essential. Quality management principles have been
integrated into OER's culture and these surveys will provide customer
satisfaction input on various elements of OER's business processes. The
approximately 14 (10 quantitative and 4 qualitative) customer
satisfaction surveys that will be conducted under this generic
clearance will gather and measure customer and partner satisfaction
with OER processes and operations. The data collected from these
surveys will provide the feedback to track and gauge satisfaction with
NIH's statutorily mandated operations and processes. OER/OD/NIH will
present data and outcomes from these surveys to inform the NIH staff,
officers, leadership, advisory committees, and other decision-making
bodies as appropriate. Based on feedback from these stakeholders, OER/
OD/NIH will formulate improvement plans and take action when necessary.
OMB approval is requested for 3 years. There are no costs to
respondents other than their time. The total estimated annualized
burden hours are 2,485.

Estimated Annualized Burden Hours

Quantitative Survey
----------------------------------------------------------------------------------------------------------------
Average
Number of Number of burden per Total annual
Type of respondent respondents responses per response (in burden hours
respondent hours)
----------------------------------------------------------------------------------------------------------------
Science professionals, applicants, reviewers, 3,820 1 15/60 995
Institutional Officials........................
Adult Science Trainees.......................... 2,000 1 15/60 500
General Public.................................. 4,000 1 15/60 1,000
Science professionals, applicants, reviewers, 12 1 1 12
Institutional Officials........................
Adult Science Trainees.......................... 6 1 1 6

[[Page 6910]]

General Public.................................. 12 1 1 12
----------------------------------------------------------------------------------------------------------------

Dated: January 29, 2014.
Seleda Perryman,
Chief Project Clearance Officer, OPERA, National Institutes of Health.
[FR Doc. 2014-02399 Filed 2-4-14; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.